Attendees

Obesity Science & Innovation will welcome 150+ researchers and leaders from biotech, big pharma, discovery innovators, solution providers, manufacturers, academics and investors. Biotech, pharma & academia from across the obesity therapeutics landscape, from innovators of GLP-1 based approaches to emerging leaders of next generation technologies demonstrating new targets and modalities to tackle obesity.